MEGHAN FEELEY: Open Payments
NPI 1578046256 · WESTFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 18 payments from 4 companies in 2025. Trend: 2023 $768 · 2024 $1,198 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $571 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $15 |
Products named: AIRSUPRA, FASENRA, Rhapsido, BREZTRI, TRELEGY ELLIPTA, NEFFY, TEZSPIRE.
Industry payments across MA — which companies pay providers there.
